Coca-Cola Embonor Statistics

Total Valuation

SNSE:EMBONOR.B has a market cap or net worth of CLP 709.49 billion. The enterprise value is 920.76 billion.

Market Cap	709.49B
Enterprise Value	920.76B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	9.28%
Float	204.05M

Valuation Ratios

The trailing PE ratio is 9.97.

PE Ratio	9.97
Forward PE	n/a
PS Ratio	0.53
PB Ratio	1.31
P/TBV Ratio	1.80
P/FCF Ratio	13.04
P/OCF Ratio	6.44
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.05, with an EV/FCF ratio of 16.92.

EV / Earnings	12.95
EV / Sales	0.68
EV / EBITDA	5.05
EV / EBIT	7.92
EV / FCF	16.92

Financial Position

The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.62.

Current Ratio	1.72
Quick Ratio	1.13
Debt / Equity	0.62
Debt / EBITDA	1.85
Debt / FCF	6.17
Interest Coverage	6.24

Financial Efficiency

Return on equity (ROE) is 13.03% and return on invested capital (ROIC) is 7.92%.

Return on Equity (ROE)	13.03%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	7.92%
Return on Capital Employed (ROCE)	13.36%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.19
Inventory Turnover	6.74

Taxes

In the past 12 months, SNSE:EMBONOR.B has paid 26.77 billion in taxes.

Income Tax	26.77B
Effective Tax Rate	27.35%

Stock Price Statistics

The stock price has increased by +17.41% in the last 52 weeks. The beta is 0.05, so SNSE:EMBONOR.B's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	+17.41%
50-Day Moving Average	1,388.62
200-Day Moving Average	1,353.20
Relative Strength Index (RSI)	64.32
Average Volume (20 Days)	202,602

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SNSE:EMBONOR.B had revenue of CLP 1.35 trillion and earned 71.13 billion in profits. Earnings per share was 139.23.

Revenue	1.35T
Gross Profit	494.41B
Operating Income	115.85B
Pretax Income	97.90B
Net Income	71.13B
EBITDA	178.71B
EBIT	115.85B
Earnings Per Share (EPS)	139.23

Full Income Statement

Balance Sheet

The company has 124.75 billion in cash and 336.00 billion in debt, giving a net cash position of -211.25 billion.

Cash & Cash Equivalents	124.75B
Total Debt	336.00B
Net Cash	-211.25B
Net Cash Per Share	n/a
Equity (Book Value)	543.00B
Book Value Per Share	1,062.88
Working Capital	159.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 110.17 billion and capital expenditures -55.75 billion, giving a free cash flow of 54.43 billion.

Operating Cash Flow	110.17B
Capital Expenditures	-55.75B
Free Cash Flow	54.43B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 36.65%, with operating and profit margins of 8.59% and 5.27%.

Gross Margin	36.65%
Operating Margin	8.59%
Pretax Margin	7.26%
Profit Margin	5.27%
EBITDA Margin	13.25%
EBIT Margin	8.59%
FCF Margin	4.03%

Dividends & Yields

SNSE:EMBONOR.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	60.36%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	10.03%
FCF Yield	7.67%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNSE:EMBONOR.B has an Altman Z-Score of 2.94 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.94
Piotroski F-Score	8